Editorials |
From The University of Texas Southwestern Medical Center at Dallas, Dallas, Tex.
Correspondence to Thomas N. Sato, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, NB11.200, Dallas, TX 75390-8573. E-mail island1005@aol.com
Key Words: vascular development\b angiogenesis Tie2 gene gene expression
| Introduction |
|---|
Endothelial cells originate from an embryonic mesoderm
during the initial phase of the vascular
development.1 However, very
little is known regarding the control mechanisms underlying the
specification of endothelial cells. The overview of the endothelial
cell specification during development is shown in the
Figure
.
A subset of mesodermal cells differentiates to a bipotential stem cell
called a hemangioblast, which differentiates to either hematopoietic or
endothelial cell lineages. Endothelial cells then assemble together to
form a rudimentary vascular network, referred to as the primary
capillary plexus.1 The
primary capillary plexus is characterized by its uniform and relatively
simple network pattern consisting of a honeycomb-like vessel branching
pattern. However, it has recently become evident that the primary
capillary plexus is made of at least two distinct types of endothelial
cells: arterial and venous endothelial
cells.2 3 An
arterial endothelial cell type is characterized by its specific
expression of ephrin-B2 and a venous type expresses specifically
EphB4.2 3 Although
we know the presence of these two types of endothelial cells at this
initial stage of the vessel formation, an origin of the arterial and
venous endothelial types remains unknown.
This article has been cited by other articles:
![]() |
M. C. Parera, M. van Dooren, M. van Kempen, R. de Krijger, F. Grosveld, D. Tibboel, and R. Rottier Distal angiogenesis: a new concept for lung vascular morphogenesis Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L141 - L149. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Reese, T. Mikawa, and D. M. Bader Development of the Coronary Vessel System Circ. Res., November 1, 2002; 91(9): 761 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Strohm, M. Barancik, M.-L. von Bruehl, M. Strniskova, C. Ullmann, R. Zimmermann, and W. Schaper Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic reconditioning Cardiovasc Res, August 15, 2002; 55(3): 602 - 618. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |